A few months ago, I wrote about the intriguing trend toward “re-launching” biotech startups that had been recently acquired by Big Pharma or Big Biotech — minus, of course, whatever promising drug ...
The patriotic design reflects EKR’s broader approach to vehicle-specific fitment, personal expression and custom automotive interiors. A vehicle can stay with someone through many stages of life. We ...
NEW YORK (AP) -- Cornerstone Therapeutics Inc. said Wednesday it completed its $125 million purchase of specialty drugmaker EKR Therapeutics. Cornerstone agreed to buy EKR in May. The deal gives it ...
EKR Therapeutics, Inc., a specialty pharmaceutical company focused on acquiring, commercializing and maximizing the potential of proprietary acute-care products, announced it has successfully ...
EKR Therapeutics Achieves Key Growth Milestone with the Acquisition of Rights from Pacira Pharmaceuticals to DepoDur, a Novel Extended-Release Opioid Analgesic for Post Operative Pain CEDAR KNOLLS, ...
EKR Therapeutics Achieves Key Growth Milestone with the Acquisition of Rights from Pacira Pharmaceuticals to DepoDur(R), a Novel Extended-Release Opioid Analgesic for Post Operative Pain CEDAR KNOLLS, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results